Open Access Open Access  Restricted Access Subscription Access
Open Access Open Access Open Access  Restricted Access Restricted Access Subscription Access

Genotoxic and Mutagenic Activity of Suvarna Bhasma


Affiliations
1 National Centre for Preclinical Reproductive and Genetic Toxicology National Institute for Research in Reproductive Health, Mumbai, India
     

   Subscribe/Renew Journal


Genetic toxicity and mutagenicity of Suvarna Bhasma (SB), an Ayurvedic drug, was determined using a battery of tests. The results of In-vivo Micronucleus assay and COMET assay did not reveal any significant increase in % Micronucleus frequency(MN) in bone marrow cells of mice and DNA damage in blood lymphocytes respectively after the oral administration of SB at various concentrations (3,-30 mg/kg bw) in treated animals as compared to vehicle control in either sex. The invitro chromosome aberration (CA) assay carried out with and without metabolic activation at different concentrations of SB in human lymphocyte culture did not cause any effect on structural or numerical chromosome aberrations. Suvarna Bhasma did not induce any mutagenic activity in presence and absence of S9 fractions in Ames assay employing three strains of salmonella typhimurium TA98, TA100 and TA102.These results demonstrated that Suvarna Bhasma preparation evaluated in this study is not genotoxic and mutagenic at the concentrations tested under the experimental conditions.

Keywords

Suvarna Bhasma, Genotoxicity, Mutagenicity, Micronucleus Assay, COMET Assay, Chromosome Aberration Assay, Ames Assay.
User
Subscription Login to verify subscription
Notifications
Font Size


  • Genotoxic and Mutagenic Activity of Suvarna Bhasma

Abstract Views: 694  |  PDF Views: 0

Authors

Nilakash Selkar
National Centre for Preclinical Reproductive and Genetic Toxicology National Institute for Research in Reproductive Health, Mumbai, India
Sharad Bhagat
National Centre for Preclinical Reproductive and Genetic Toxicology National Institute for Research in Reproductive Health, Mumbai, India
Mukesh Chawada
National Centre for Preclinical Reproductive and Genetic Toxicology National Institute for Research in Reproductive Health, Mumbai, India
Mahesh K. Vahalia
National Centre for Preclinical Reproductive and Genetic Toxicology National Institute for Research in Reproductive Health, Mumbai, India
Anand Puranik
National Centre for Preclinical Reproductive and Genetic Toxicology National Institute for Research in Reproductive Health, Mumbai, India
Geeta Vanage
National Centre for Preclinical Reproductive and Genetic Toxicology National Institute for Research in Reproductive Health, Mumbai, India

Abstract


Genetic toxicity and mutagenicity of Suvarna Bhasma (SB), an Ayurvedic drug, was determined using a battery of tests. The results of In-vivo Micronucleus assay and COMET assay did not reveal any significant increase in % Micronucleus frequency(MN) in bone marrow cells of mice and DNA damage in blood lymphocytes respectively after the oral administration of SB at various concentrations (3,-30 mg/kg bw) in treated animals as compared to vehicle control in either sex. The invitro chromosome aberration (CA) assay carried out with and without metabolic activation at different concentrations of SB in human lymphocyte culture did not cause any effect on structural or numerical chromosome aberrations. Suvarna Bhasma did not induce any mutagenic activity in presence and absence of S9 fractions in Ames assay employing three strains of salmonella typhimurium TA98, TA100 and TA102.These results demonstrated that Suvarna Bhasma preparation evaluated in this study is not genotoxic and mutagenic at the concentrations tested under the experimental conditions.

Keywords


Suvarna Bhasma, Genotoxicity, Mutagenicity, Micronucleus Assay, COMET Assay, Chromosome Aberration Assay, Ames Assay.

References





DOI: https://doi.org/10.22506/ti%2F2016%2Fv23%2Fi3%2F146714